{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:16Z","timestamp":1791011956564,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jbspin.2011.10.007","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T11:28:35Z","timestamp":1323084515000},"page":"471-475","source":"Crossref","is-referenced-by-count":31,"title":["TGF beta1 polymorphisms are candidate predictors of the clinical response to rituximab in rheumatoid arthritis"],"prefix":"10.1016","volume":"79","author":[{"given":"Claire Immediato","family":"Da\u00efen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Rittore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Da\u00efen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Cadart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Daur\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2011.10.007_bib0005","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0010","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0015","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0020","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","author":"Duddy","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.173.2.487","article-title":"Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells","volume":"173","author":"Roosnek","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0030","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jbspin.2010.09.020","article-title":"Rituximab therapy for AA-amyloidosis secondary to rheumatoid arthritis","volume":"78","author":"Narvaez","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/art.30233","article-title":"B-cell activation biomarkers as predictive factors of the response to rituximab in rheumatoid arthritis","volume":"63","author":"Sellam","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.23092","article-title":"Influence of -308 A\/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis","volume":"57","author":"Guis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/rheumatology\/kep314","article-title":"Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis","volume":"48","author":"Quartuccio","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0055","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1002\/art.22967","article-title":"Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment","volume":"56","author":"Teng","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/ard.2007.080960","article-title":"Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response","volume":"67","author":"Thurlings","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/ard.2007.074229","article-title":"Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results","volume":"67","author":"Kavanaugh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0070","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.23473","article-title":"Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment","volume":"58","author":"Roll","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0075","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/rheumatology\/keh662","article-title":"The response to anti-TNF-alpha treatment: gene regulation at the bedside","volume":"44","author":"de Vries","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00296-006-0175-7","article-title":"Association of TNF-alpha -308 G\/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis","volume":"27","author":"Lee","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0085","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.11168","article-title":"Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis","volume":"48","author":"Mugnier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/gene.2008.77","article-title":"Rheumatoid arthritis: a view of the current genetic landscape","volume":"10","author":"Coenen","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jbspin.2010.08.017","article-title":"Cell and cytokine imbalances in rheumatoid synovitis","volume":"78","author":"Boissier","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0105","first-page":"31","article-title":"Rituximab therapy in rheumatoid arthritis in daily practice","volume":"35","author":"Assous","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/ard.62.9.907","article-title":"Transforming growth factor beta 1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population","volume":"62","author":"Pokorny","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/rheumatology\/keh689","article-title":"Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis","volume":"44","author":"Oen","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbspin.2010.10.003","article-title":"Using targeted therapies alone for rheumatoid arthritis","volume":"78","author":"Prati","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/CS19980154","article-title":"Transforming growth factor-beta1 gene polymorphisms and coronary artery disease","volume":"95","author":"Syrris","year":"1998","journal-title":"Clin Sci"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0130","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","article-title":"Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation","volume":"66","author":"Awad","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0135","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/S0041-1345(02)03483-8","article-title":"Role of codon 10 and codon 25 polymorphisms on TGF-beta 1 gene expression and protein synthesis in stable renal allograft recipients","volume":"34","author":"Guo","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0140","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/01.CIR.101.24.2783","article-title":"Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese","volume":"101","author":"Yokota","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0145","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1359\/jbmr.1998.13.10.1569","article-title":"Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women","volume":"13","author":"Yamada","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0150","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S1286-4579(99)00254-3","article-title":"The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes","volume":"1","author":"Lebman","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jbspin.2011.10.007_bib0155","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.146.11.4016","article-title":"Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA","volume":"146","author":"Kehrl","year":"1991","journal-title":"J Immunol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11002466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11002466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T12:23:38Z","timestamp":1686486218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X11002466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1297319X11002466"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2011.10.007","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}